Skip to main content
OpenTrials
Completed

NCT Number: NCT03507426

Retrobulbar Block Versus Ketamine Infusion for Post-enucleation Analgesia

This study compares the efficacy and safety of two techniques, retrobulbar block versus intra-operative ketamine infusion, for control of post-operative pain occurring in patients undergoing ocular enucleation or evisceration performed under general anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kasr Al-Ainy Hospital, Cairo University

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ocular enucleation candidate patients
  • Ocular evisceration candidate patients

Exclusion criteria

  • Any condition contra-indicating general or local anesthesia
  • Allergy to any of the drugs used during the procedure

Treatment and study plan

Retrobulbar block

Procedure

Patients will receive a single retrobulbar injection with 3-4ml of an equal mixture of Lidocaine 2% & Bupivacaine 0.5% + Hyaluronidase (10 IU/ml), after induction of general anesthesia.

Other names: Local analgesia

Ketamine

Procedure

Patients will receive a 0.5 mg/kg bolus followed by an infusion of 0.25 mg/kg/h of intravenous Ketamine, after induction of general anesthesia.

Other names: IV analgesia

Primary outcomes

  1. Time to the first post-operative rescue analgesia.

    Time frame: 24 hours

    Time (measured in minutes) elapsed till the patient requires to receive his first post-operative rescue analgesic dose.

Sponsors and collaborators

Lead sponsor

Nazmy Edward Seif

Other

Registry information

Official study title

Retrobulbar Block Versus Ketamine Infusion as Adjuvants to General Anesthesia for Post-operative Pain Control After Enucleation

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Apr 25, 2018
Registry last updated
Jul 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.